Hospital-based prevalence of culture-confirmed melioidosis among high-risk patients in India, 2023–25: a multicentre prospective study

The Lancet Global Health · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles